IONS — IONIS PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 549 SEC-registered investment managers reported holding IONS (IONIS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $12.01B across 472.85M shares. That is -2.0% by share count (-9.23M shares) versus the previous quarter, while reported value moved +8.9%. Ownership is concentrated: the five largest holders account for 42.7% of reported value and the top ten for 54.1%.
Compared with the prior quarter, 68 opened new positions, 200 added to existing stakes, 171 trimmed, 50 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of IONIS PHARMACEUTICALS INC (IONS) include Capital World Investors, Vanguard Group, Capital World Investors, ranked by reported 13F value among the 889 institutional holders on this page.
IONS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding IONS
The superinvestors we track who report IONS in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 1.79M | $80.08M | 6.52% | Reduce |
|
|
Q3 2026 | 923.16K | $41.22M | 0.24% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 361 | 787.96M | $3.70B | +488.6% |
| Q2 2026 | 549 | 472.85M | $12.01B | -2.0% |
| Q1 2026 | 529 | 493.06M | $10.56B | +26.1% |
| Q4 2025 | 532 | 553.78M | $10.48B | -10.5% |
| Q3 2025 | 464 | 630.16M | $8.47B | -23.3% |
| Q2 2025 | 394 | 727.27M | $5.76B | -5.6% |
| Q1 2025 | 365 | 766.73M | $99.60B | +37.6% |
| Q4 2024 | 383 | 593.74M | $90.85B | +4.3% |
Over the 8 quarters shown, institutional share counts increased 33% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+37.6%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 21.79M | $972.80M | 0.12% | Add | |
| 7.72M | $344.67M | 0.02% | Reduce | |
| 7.22M | $322.31M | 0.01% | Hold | |
| 3.28M | $146.38M | 0.01% | Reduce | |
| 3.14M | $140.38M | 0.01% | Add | |
| 2.40M | $107.15M | 0.35% | Add | |
| 2.00M | $89.11M | 0.18% | Add | |
| 1.94M | $87.25M | 0.09% | Add | |
| 1.79M | $80.08M | 6.52% | Reduce | |
| 1.51M | $67.35M | 0.03% | Add | |
| 1.34M | $59.89M | 0.51% | Add | |
| 50.00M | $55.12M | 5.38% | Add | |
| 1.16M | $51.69M | 0.02% | Reduce | |
| 1.09M | $48.54M | 9.44% | Add | |
| 1.07M | $47.83M | 0.01% | Add | |
| 522.32K | $41.41M | 0.11% | Hold | |
| 923.16K | $41.22M | 0.24% | Add | |
| 776.11K | $34.65M | 0.38% | Add | |
| 755.02K | $33.83M | 0.15% | Add | |
| 754.00K | $33.67M | 0.54% | Add | |
| 641.41K | $28.64M | 0.01% | Reduce | |
| 621.92K | $27.77M | 0.01% | Reduce | |
| 603.36K | $26.94M | 0.05% | Reduce | |
| 599.83K | $26.78M | 4.55% | New | |
| 557.50K | $24.89M | 0.21% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 16.71M | $660.40M | 0.01% | Add | |
| 16.05M | $634.09M | 0.40% | Reduce | |
| 12.54M | $495.46M | 0.07% | Add | |
| 12.54M | $495.46M | 0.07% | Add | |
| 7.85M | $310.28M | 6.84% | Hold | |
| 4.89M | $193.26M | 6.21% | Add | |
| 3.80M | $150.14M | 0.25% | Add | |
| 3.13M | $123.51M | 0.01% | Reduce | |
| 2.89M | $114.26M | 10.82% | Reduce | |
| 2.89M | $114.25M | 0.01% | Add | |
| 2.67M | $105.40M | 0.22% | Add | |
| 2.65M | $104.68M | 0.18% | Add | |
| 2.65M | $104.68M | 0.05% | Add | |
| 76.62M | $77.39M | 1.38% | Add | |
| 1.91M | $75.60M | 2.70% | Hold | |
| 1.79M | $70.66M | 0.14% | Add | |
| 64.95M | $65.45M | 1.38% | Add | |
| 60.43M | $61.04M | 3.14% | Add | |
| 1.53M | $60.42M | 0.04% | Reduce | |
| 1.49M | $58.78M | 0.01% | Add | |
| 1.49M | $58.78M | 0.01% | Add | |
| 57.35M | $58.04M | 4.21% | Add | |
| 1.43M | $56.66M | 0.07% | Reduce | |
| 54.91K | $55.64M | 10.84% | Hold | |
| 46.70M | $49.18M | 1.39% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 3.58M sh · $294.75M
- Sixth Street Partners Management Company, L.P. 1.61M sh · $127.26M
- Capital International Investors 823.76K sh · $65.32M
- Freestone Grove Partners LP 339.97K sh · $26.96M
- Life Cycle Investment Partners Ltd 219.90K sh · $17.44M
- Eagle Health Investments LP 194.58K sh · $15.43M
- PICTON MAHONEY ASSET MANAGEMENT 5.00M sh · $7.77M
- BANK OF NOVA SCOTIA 68.55K sh · $5.44M
- Jupiter Topco LLC 68.19K sh · $5.41M
- Y-Intercept (Hong Kong) Ltd 67.37K sh · $5.34M
- SCHRODER INVESTMENT MANAGEMENT GROUP 58.87K sh · $4.75M
- Sovran Advisors, LLC 84.98K sh · $4.70M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 11.90M sh · $18.05M
- Zurich Insurance Group Ltd/FI sold 239.65K sh · $17.99M
- ARISTEIA CAPITAL, L.L.C. sold 10.00M sh · $15.09M
- WINTON GROUP Ltd sold 106.53K sh · $8.00M
- Lisanti Capital Growth, LLC sold 75.70K sh · $5.68M
- Janus Henderson Group sold 68.19K sh · $5.12M
- WEST MICHIGAN ADVISORS, LLC sold 44.61K sh · $3.35M
- PRELUDE CAPITAL MANAGEMENT, LLC sold 29.66K sh · $2.23M
- LOOMIS SAYLES & CO L P sold 28.62K sh · $2.15M
- STEMPOINT CAPITAL LP sold 26.39K sh · $1.98M
- FLORIDA FINANCIAL ADVISORS, LLC sold 25.89K sh · $1.94M
- Informed Momentum Co LLC sold 20.61K sh · $1.55M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital World Investors | 21.79M | 21.67M | 21.19M | 17.96M | 12.72M | 12.54M | 12.36M | 11.47M | 7.83M | 2.25M | 839.46K | 839.46K | 839.46K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.72M | 7.86M | 7.81M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.22M | 7.21M | 7.12M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.28M | 3.58M | 3.98M | 3.15M | 3.07M | 2.89M | 2.84M | 2.69M | 2.67M | 2.48M | 2.36M | 2.28M | 2.19M | 2.16M | 2.07M | 2.01M | 1.90M | 1.87M | 1.90M | 1.83M |
| Morgan Stanley | 3.14M | 1.28M | 94.00K | 80.00K | 12.78M | 15.03M | 17.66M | 1.07M | 1.30M | 31.00K | 6.74M | 6.74M | 7.09M | 6.58M | 5.72M | 5.40M | 1.55M | 3.72M | 20.00K | 20.00K |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2.40M | 4.23K | 3.50K | 3.16K | 3.09K | 9.56K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 2.00M | 333.95K | 42.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.94M | 1.60M | 1.43M | 1.42M | 1.39M | 608.64K | 618.55K | 620.80K | 1.30M | 2.41M | 3.74M | 3.52M | 3.24M | — | — | — | — | — | — | — |
| Tweedy, Browne Co LLC | 1.79M | 2.28M | 2.28M | 2.46M | 2.90M | 2.89M | 2.98M | 3.25M | 3.45M | 3.45M | 3.45M | 3.45M | 3.51M | — | — | — | — | — | — | — |
| UBS Group AG | 1.51M | 132.00K | 120.00K | 1.05M | 17.00K | 1.53M | 1.89M | 1.92M | 167.88K | 152.67K | 171.76K | 1.00K | 109.03K | 92.83K | 100.95K | 161.47K | 6.00K | 8.00K | 8.00K | 8.00K |
| GW&K Investment Management, LLC | 1.34M | 746.97K | 779.35K | 786.67K | 264.01K | 448.83K | 182.31K | 187.22K | — | — | — | — | — | — | — | — | — | — | — | — |
| DLD Asset Management, LP | 50.00M | 40.00K | 55.00M | 12.40K | 27.40K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 1.16M | 1.95M | 1.66M | 1.62M | 1.37M | 472.75K | 116.77K | — | 6.29K | 13.44K | 13.38K | 13.22K | 12.98K | — | — | — | — | — | — | — |
| Davern Capital Partners, LP | 1.09M | 798.71K | 386.90K | 238.48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.07M | 1.06M | 1.02M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 522.32K | 522.32K | 523.93K | 422.90K | 473.94K | 668.27K | 500.45K | 65.79K | 56.70K | 52.55K | 28.74K | 29.84K | 36.58K | — | — | — | — | — | — | — |
| ARK Invest | 923.16K | 300.77K | 288.72K | 422.97K | 631.22K | 900.32K | 1.00M | 1.03M | 1.38M | 1.36M | 1.40M | 1.91M | 2.37M | 2.42M | 2.64M | 2.67M | 3.71M | 4.70M | 6.17M | 7.08M |
| CAPITAL FUND MANAGEMENT S.A. | 776.11K | 329.55K | 142.20K | — | — | 31.22K | 58.01K | — | 30.69K | — | — | — | — | — | — | — | — | — | — | — |
| Candriam S.C.A. | 755.02K | 445.02K | 484.05K | 677.63K | 611.24K | 724.74K | 993.70K | 849.82K | 948.27K | 948.27K | 911.90K | 629.07K | 549.07K | — | — | — | — | — | — | — |
| Carmignac Gestion | 754.00K | 321.00K | 53.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold IONS?
As of 2026-Q2, 549 institutional funds reported holding IONS (IONIS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $12.01B.
How many shares of IONS do institutions own?
13F filers reported 472.85M shares of IONS, worth $12.01B in aggregate at the end of 2026-Q2.
Is institutional ownership of IONS rising or falling?
Share counts moved -2.0% versus the prior quarter — distribution.
Who are the top institutional holders of IONS?
The largest 13F holders are Capital World Investors, Vanguard Group, Capital World Investors, Two Sigma Investments, VANGUARD PORTFOLIO MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of IONIS PHARMACEUTICALS INC?
The major shareholders of IONIS PHARMACEUTICALS INC (IONS) by reported 13F value are Capital World Investors, Vanguard Group, Capital World Investors, Two Sigma Investments, VANGUARD PORTFOLIO MANAGEMENT LLC, among 889 institutional holders.
Which legendary investors own IONS?
2 of the legendary investors tracked on HoldingsHub report IONS (IONIS PHARMACEUTICALS INC) in their latest 13F filings, led by Tweedy Browne, ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on IONS?
2 tracked superinvestors hold IONS simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.